Pro-Statins Study Have Multiple Links With Big Pharma

| February 18, 2017

In my last blog post, I told you how Big Pharma is attempting to persuade doctors and patients alike that their statin drugs are safe, that their benefits outweigh the side-effects, and that they need to be prescribed more, not less. In a recently-published article in the prestigious American Journal of Medicine, two eminent medical academics dismiss the link between statins and diabetes as irrelevant and urge greater use of the drugs – flying in the face of many research findings.

So, could the authors’ opinions possibly be biased? Well, according to their declared conflicts of interest, the two main authors of this paper, Profs Charles H. Hennekens and Marc A. Pfeffer, between them notch up a total of 31 nice little earners with pharmaceutical companies, including advisory and consultancy work and research funding.

In order that the profs’ paper wouldn’t be overlooked, the editor-in-chief of The American Journal of Medicine, Dr Joseph S Alpert, obligingly wrote an editorial supporting their views. And, as it turns out, Dr Alpert is also a consultant or advisory committee member for at least 18 separate pharmaceutical firms.

The fact Big Pharma has much of the medical profession, academia and scientific media in its pocket is nothing new. And neither is its quest for new uses for existing drugs. That means we need to take any new pronouncements about the benefits of statins, or any other drugs for that matter, with a large pinch of salt. Like the recent ‘discovery’ that statins could prevent deep vein thrombosis in bed-bound hospital patients.

In this study, researchers at Leicester University carried out a meta-analysis of 36 individual trials and concluded that statin use cuts the risk of this dangerous type of blood clot by 15 to 25 per cent.1 I won’t say it doesn’t, but I’ll keep in mind the study I mentioned in my last blog post that revealed how the dubious statistical methods used in some statin trials made trivial reductions in risk appear a whole lot more important than they really were.

In my next blog post I’ll be taking another look at environmental pollutants and the finding that some insecticides mimic the effects of the hormone melatonin – upsetting our body clocks and increasing the risk of type 2 diabetes.

Wishing you the best of health,

Martin Hum
PhD DHD Nutritionist
for Real Diabetes Truth

Bear in mind we are not addressing anyone’s personal situation and you should rely on this for informational purposes only. Please consult with your own physician before acting on any recommendations contained herein.

Sources

1. Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol. 2017; 4(2):e83-e93.

 

Print Friendly

Tags: , , ,

Category: Diabetes News Views

Comments are closed.